Cost-effectiveness analysis model for sotagliflozin compared with insulin monotherapy for patients with type 1 diabetes and chronic kidney disease

That is the title of my latest paper in JMCP with co-authors Jaehong Kim, Shanshan Wang, Moises Marin, Slaven Sikirica, and Mariam Anderson. The study abstract is below. BACKGROUND: Patients with type 1 diabetes (T1D) have a greater than 50% lifetime risk of developing comorbid chronic kidney disease (CKD). Glycemic control can reduce diabetes-related complications…

Read More

Is “inflammaging” inevitable?

Based on a recent study in Nature Aging as summarized in the New York Times: Inflammation is a natural immune response that protects the body from injury or infection. Scientists have long believed that long-term, low-grade inflammation — also known as “inflammaging” — is a universal hallmark of getting older. But this new data raises…

Read More

Matthew Explores the Referral Process

So I thought I would try a little experiment. Following up on a recent primary care visit I got a couple of referrals. I went investigating as to what I could find out about the where to go and what the cost might be. And what the connection if any between my primary care group…

Read More

Journalists Break Down Reconciliation Bill, Vaccine Panel Meeting, and ‘Dobbs’ Anniversary

KFF Health News senior correspondent Phil Galewitz discussed Medicaid and Supplemental Nutrition Assistance Program cuts on “CBS Morning News” on June 26. Click here to watch Galewitz on “CBS Morning News” Read Galewitz and Stephanie Armour’s “Too Sick To Work, Some Americans Worry Trump’s Bill Will Strip Their Health Insurance” KFF Health News senior correspondent…

Read More